Human herpes virus-8-negative primary effusion lymphoma in a patient with common variable immunodeficiency

Akiko Hisamoto, Hiromichi Yamane, Akio Hiraki, Yoshinobu Maeda, Nobuharu Fujii, Kenji Sasaki, Toshitugu Miyake, Takashi Sasaki, Tohru Nakamura, Katsuyuki Kiura, Mitsune Tanimoto, Haruhito Kamei

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Primary effusion lymphoma (PEL) is a newly described high-grade B cell lymphoma developing in association with human herpes virus type 8 (HHV-8) in human immunodeficiency virus (HIV)-infecting individuals. Common variable immunodeficiency (CVID) is a primary immunodeficiency disease characterized by reduced serum immunoglobulin and heterogeneous clinical features. The risk of cancer in CVID patients is increased. Here, we describe a PEL that developed in the pleural and pericardial cavities of an HIV-negative and HHV-8-negative patient with CVID.

Original languageEnglish
Pages (from-to)2019-2022
Number of pages4
JournalLeukemia and Lymphoma
Volume44
Issue number11
DOIs
Publication statusPublished - Nov 2003

Fingerprint

Primary Effusion Lymphoma
Common Variable Immunodeficiency
Viruses
HIV
Pleural Cavity
Pericardium
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Immunoglobulins
Serum
Neoplasms

Keywords

  • Common variable immunodeficiency
  • Human herpes virus 8
  • Non-Hodgkin's lymphoma
  • Primary effusion lymphoma

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Human herpes virus-8-negative primary effusion lymphoma in a patient with common variable immunodeficiency. / Hisamoto, Akiko; Yamane, Hiromichi; Hiraki, Akio; Maeda, Yoshinobu; Fujii, Nobuharu; Sasaki, Kenji; Miyake, Toshitugu; Sasaki, Takashi; Nakamura, Tohru; Kiura, Katsuyuki; Tanimoto, Mitsune; Kamei, Haruhito.

In: Leukemia and Lymphoma, Vol. 44, No. 11, 11.2003, p. 2019-2022.

Research output: Contribution to journalArticle

Hisamoto, A, Yamane, H, Hiraki, A, Maeda, Y, Fujii, N, Sasaki, K, Miyake, T, Sasaki, T, Nakamura, T, Kiura, K, Tanimoto, M & Kamei, H 2003, 'Human herpes virus-8-negative primary effusion lymphoma in a patient with common variable immunodeficiency', Leukemia and Lymphoma, vol. 44, no. 11, pp. 2019-2022. https://doi.org/10.1080/1042819031000110955
Hisamoto, Akiko ; Yamane, Hiromichi ; Hiraki, Akio ; Maeda, Yoshinobu ; Fujii, Nobuharu ; Sasaki, Kenji ; Miyake, Toshitugu ; Sasaki, Takashi ; Nakamura, Tohru ; Kiura, Katsuyuki ; Tanimoto, Mitsune ; Kamei, Haruhito. / Human herpes virus-8-negative primary effusion lymphoma in a patient with common variable immunodeficiency. In: Leukemia and Lymphoma. 2003 ; Vol. 44, No. 11. pp. 2019-2022.
@article{4d26222bffea45c4ada6fbdbc11d3491,
title = "Human herpes virus-8-negative primary effusion lymphoma in a patient with common variable immunodeficiency",
abstract = "Primary effusion lymphoma (PEL) is a newly described high-grade B cell lymphoma developing in association with human herpes virus type 8 (HHV-8) in human immunodeficiency virus (HIV)-infecting individuals. Common variable immunodeficiency (CVID) is a primary immunodeficiency disease characterized by reduced serum immunoglobulin and heterogeneous clinical features. The risk of cancer in CVID patients is increased. Here, we describe a PEL that developed in the pleural and pericardial cavities of an HIV-negative and HHV-8-negative patient with CVID.",
keywords = "Common variable immunodeficiency, Human herpes virus 8, Non-Hodgkin's lymphoma, Primary effusion lymphoma",
author = "Akiko Hisamoto and Hiromichi Yamane and Akio Hiraki and Yoshinobu Maeda and Nobuharu Fujii and Kenji Sasaki and Toshitugu Miyake and Takashi Sasaki and Tohru Nakamura and Katsuyuki Kiura and Mitsune Tanimoto and Haruhito Kamei",
year = "2003",
month = "11",
doi = "10.1080/1042819031000110955",
language = "English",
volume = "44",
pages = "2019--2022",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "11",

}

TY - JOUR

T1 - Human herpes virus-8-negative primary effusion lymphoma in a patient with common variable immunodeficiency

AU - Hisamoto, Akiko

AU - Yamane, Hiromichi

AU - Hiraki, Akio

AU - Maeda, Yoshinobu

AU - Fujii, Nobuharu

AU - Sasaki, Kenji

AU - Miyake, Toshitugu

AU - Sasaki, Takashi

AU - Nakamura, Tohru

AU - Kiura, Katsuyuki

AU - Tanimoto, Mitsune

AU - Kamei, Haruhito

PY - 2003/11

Y1 - 2003/11

N2 - Primary effusion lymphoma (PEL) is a newly described high-grade B cell lymphoma developing in association with human herpes virus type 8 (HHV-8) in human immunodeficiency virus (HIV)-infecting individuals. Common variable immunodeficiency (CVID) is a primary immunodeficiency disease characterized by reduced serum immunoglobulin and heterogeneous clinical features. The risk of cancer in CVID patients is increased. Here, we describe a PEL that developed in the pleural and pericardial cavities of an HIV-negative and HHV-8-negative patient with CVID.

AB - Primary effusion lymphoma (PEL) is a newly described high-grade B cell lymphoma developing in association with human herpes virus type 8 (HHV-8) in human immunodeficiency virus (HIV)-infecting individuals. Common variable immunodeficiency (CVID) is a primary immunodeficiency disease characterized by reduced serum immunoglobulin and heterogeneous clinical features. The risk of cancer in CVID patients is increased. Here, we describe a PEL that developed in the pleural and pericardial cavities of an HIV-negative and HHV-8-negative patient with CVID.

KW - Common variable immunodeficiency

KW - Human herpes virus 8

KW - Non-Hodgkin's lymphoma

KW - Primary effusion lymphoma

UR - http://www.scopus.com/inward/record.url?scp=10744219773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744219773&partnerID=8YFLogxK

U2 - 10.1080/1042819031000110955

DO - 10.1080/1042819031000110955

M3 - Article

C2 - 14738159

AN - SCOPUS:10744219773

VL - 44

SP - 2019

EP - 2022

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 11

ER -